Concentra Group Holdings Parent, Inc., a prominent player in the health care sector, has recently filed a Rule 144 notice with the Securities and Exchange Commission (SEC). This filing, dated August 3, 2026, announces the sale of a substantial block of its common shares. The transaction is being facilitated by UBS Financial Services Inc. and involves a single director, Robert A. Ortenzio, who is selling shares held through his trust.
The shares in question were acquired through private purchases dating back to 1997. The sale is structured in multiple tranches throughout the month of July, with a total of 130,000 shares sold under the trust. Additionally, more than 250,000 shares were sold in the same period, bringing the total number of shares sold to over 380,000.
This transaction is conducted under the requirements of the Securities Act, ensuring compliance with all regulatory standards. The filing confirms that no other securities have been sold by the owner in the preceding three months, highlighting the specificity and exclusivity of this transaction.
Concentra Group Holdings Parent, Inc., headquartered in Addison, Texas, operates in the health care sector, providing a range of occupational health services across the United States. The company is structured into three primary segments: Occupational Health centers, Onsite health clinics, and Other business. Its services encompass workers compensation, employer and consumer health services, and employer-sponsored primary care services at workplaces. These services include mobile health and episodic specialty testing services.
Additionally, the company operates Concentra Telemed, a telemedicine platform designed for the treatment of work-related injuries and illnesses. Concentra Pharmacy, another division, focuses on distributing repackaged medications. The company also manages Concentra Medical Compliance Administration, a third-party administrator that assists employers in managing abuse testing programs for both regulated and non-regulated workforces.
Concentra Group Holdings Parent, Inc. offers a comprehensive suite of services, including injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, vaccinations, and other preventive care measures. These services are designed to protect employees from workplace hazards.
As of August 4, 2026, the company’s close price stood at $30.76, with a 52-week high of $32.86 recorded on July 28, 2026, and a 52-week low of $18.545 on November 5, 2025. The market capitalization of the company is valued at approximately $3.98 billion USD. Concentra Group Holdings Parent, Inc. is listed on the New York Stock Exchange and operates primarily in the United States.
